<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathogenesis and clinical manifestations of disseminated histoplasmosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathogenesis and clinical manifestations of disseminated histoplasmosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathogenesis and clinical manifestations of disseminated histoplasmosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John W Baddley, MD, MSPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 19, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Histoplasmosis is the most prevalent endemic mycosis in the United States [<a href="#rid1">1</a>]. While most infections are asymptomatic or self-limited, some individuals develop acute pulmonary infections or severe disseminated infection [<a href="#rid2">2-5</a>]. </p><p>The pathogenesis of disseminated histoplasmosis, risk factors for dissemination, and clinical features of the infection will be reviewed here. The diagnosis and treatment of this infection and the manifestations of localized pulmonary histoplasmosis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2461.html" rel="external">"Diagnosis and treatment of disseminated histoplasmosis in patients without HIV"</a> and  <a class="medical medical_review" href="/z/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis"</a> and  <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV"</a> and  <a class="medical medical_review" href="/z/d/html/6996.html" rel="external">"Treatment of histoplasmosis in patients with HIV"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span><em>Histoplasma capsulatum</em> is a thermally dimorphic fungus, growing as a mold in the environment and as a yeast at 37°C. Infection develops when <em>Histoplasma </em>microconidia are inhaled into the lungs, where they change into the yeast form. Neutrophils, macrophages, lymphocytes, and natural killer (NK) cells are attracted in response to the infection. As in tuberculosis, macrophages assist in spreading the organism via lymphatics to the adjacent lymph nodes and from there by hematogenous spread throughout the reticuloendothelial system (liver, spleen, lymph nodes, and bone marrow).</p><p>In patients with disseminated infection, macrophages are typically engorged with yeasts, supporting the important role of intracellular proliferation of the organism. Organisms are confined to macrophages but less commonly can be seen within the tissue spaces as well as in peripheral white blood cells  (<a class="graphic graphic_picture graphicRef57613" href="/z/d/graphic/57613.html" rel="external">picture 1</a>).</p><p>T cell immunity plays the predominant role in recovery from histoplasmosis [<a href="#rid6">6</a>]. Once cellular immunity to <em>Histoplasma</em> develops, macrophages become activated to kill the organism. Cytokines including interleukin (IL)-12 and interferon (IFN)-gamma trigger macrophages to kill the fungus and halt progression of disease [<a href="#rid7">7-9</a>].</p><p>Failure to activate macrophage fungicidal capacity is likely the key defect in immunity to <em>H. capsulatum</em> in patients with disseminated histoplasmosis. In one study in mice with severe combined immunodeficiency, administration of exogenous IL-12 increased IFN-gamma, tumor necrosis factor (TNF)-alpha, and nitric oxide production in splenocytes, resulting in decreased colony counts of <em>H. capsulatum</em> and increased survival [<a href="#rid10">10</a>]; administration of IFN-gamma antibody eliminated the protective effect of IL-12 in this model. The important role of TNF-alpha and IFN-gamma in patients with histoplasmosis is substantiated by the occurrence of severe disease in those receiving TNF-alpha inhibitor therapy [<a href="#rid11">11,12</a>] and in hosts with IFN-gamma receptor deficiency [<a href="#rid13">13,14</a>].</p><p>These defense mechanisms are generally sufficient to control the infection in immunocompetent individuals, explaining the subclinical or self-limited course characteristic of acute histoplasmosis. Although hematogenous dissemination probably occurs in most patients during the acute infection before cellular immunity develops, progressive illness is unusual except in the host with altered immunity [<a href="#rid2">2,3,15</a>]. Individuals with underlying conditions such as AIDS, or who are receiving immunosuppressive medications that impair these defenses, are at risk for developing more severe, and often fatal, progressive forms of infection.</p><p class="headingAnchor" id="H3"><span class="h2">Reinfection and reactivation of infection</span><span class="headingEndMark"> — </span>Reinfection can occur in patients who previously had documented histoplasmosis. In persons with impaired immunity or in those who have a massive reexposure to <em>H. capsulatum</em>, host defenses against this organism can be overwhelmed and disease can recur.</p><p>Reactivation of latent histoplasmosis can also occur in immunocompromised patients [<a href="#rid15">15,16</a>]. Presumably, viable organisms persist in the tissues following recovery from the initial (often asymptomatic) episode of histoplasmosis. Development of disseminated histoplasmosis in individuals who left the endemic area years before is thought to be caused by reactivation of these quiescent foci. The finding of a mitochondrial DNA pattern characteristic of Panamanian strains of <em>H. capsulatum</em> in five patients who had moved from Puerto Rico to New York City provides convincing evidence for reactivation [<a href="#rid17">17</a>].</p><p>Cases of progressive pulmonary or disseminated histoplasmosis occurring shortly after initiation of immunosuppressive therapy with TNF-alpha inhibitors [<a href="#rid11">11,12,18</a>] could represent worsening of smoldering infection exacerbated by recently intensified immunosuppression, newly acquired infection, or reactivation. (See  <a class="medical medical_review" href="/z/d/html/1410.html" rel="external">"Tumor necrosis factor-alpha inhibitors: Bacterial, viral, and fungal infections", section on 'Histoplasmosis'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>Three types of tissue response have been described in disseminated histoplasmosis: diffuse histiocytosis, focal histiocytosis, and tuberculoid granulomas [<a href="#rid2">2</a>]. Histiocytosis refers to macrophage infiltration into the infected tissues. In comparison, infiltration of neutrophils, lymphocytes, and plasma cells are not usually noted in the tissues of patients with disseminated histoplasmosis. Granulomas are seen less often with disseminated infection than with other types of histoplasmosis and usually are seen in patients with lower fungal burdens  (<a class="graphic graphic_picture graphicRef56193" href="/z/d/graphic/56193.html" rel="external">picture 2</a>) [<a href="#rid2">2</a>]. </p><p>Perivasculitis with necrosis can be seen on histopathological examination of biopsy material from patients with more severe infection. Heavy infections may also cause marked enlargement of the involved organs (eg, liver, spleen, adrenal glands, lymph nodes), occasionally displacing normal parenchymal cells and causing organ dysfunction. At autopsy, many patients with disseminated histoplasmosis demonstrate involvement of these organs, as well as gastrointestinal tract mucosa [<a href="#rid2">2</a>]. Autopsy experience is biased toward the severe end of the disease spectrum, however, and the extent of dissemination to various organs is not well documented in milder cases. </p><p class="headingAnchor" id="H5"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Most patients with disseminated histoplasmosis have underlying conditions (eg, immunosuppressive disorders, HIV infection) or take medications, such as antirejection transplant medications and tumor necrosis factor (TNF)-alpha inhibitors, that impair their ability to defend against intracellular pathogens [<a href="#rid5">5,15,19,20</a>]. </p><p class="headingAnchor" id="H6"><span class="h2">Transplant recipients</span><span class="headingEndMark"> — </span>Solid organ transplantation is a risk factor for disseminated histoplasmosis [<a href="#rid21">21-23</a>]. Infection in solid organ transplant recipients can occur as a new infection by inhalation of conidia or by reactivation of quiescent disease. Infection can also be transmitted from the transplant donor [<a href="#rid24">24-26</a>]. This was illustrated in a report of two kidney transplant recipients who developed disseminated histoplasmosis eight and nine months after transplantation. The recipients lived in different states from one another, neither of which were endemic regions, had never traveled to endemic areas, and had no prior serologic evidence of exposure to the fungus [<a href="#rid24">24</a>]. Both received cadaveric kidneys from the same donor who had serum antibody titers of 1:16 by complement fixation, and their isolates of <em>H. capsulatum</em> had identical patterns by both polymerase chain reaction and DNA analysis, reflecting transmission from the organs. (See <a class="local">'Reinfection and reactivation of infection'</a> above and  <a class="medical medical_review" href="/z/d/html/1396.html" rel="external">"Infection in the solid organ transplant recipient", section on 'Donor-derived infections'</a>.)</p><p>In a multicenter study of 152 cases of histoplasmosis in solid organ transplant recipients over an eight-year period, 81 percent had disseminated disease and 28 percent of patients had severe histoplasmosis requiring intensive care unit admission [<a href="#rid22">22</a>]. The median time from transplantation to diagnosis was 27 months, but 34 percent of patients were diagnosed during the first year after transplantation.</p><p>Histoplasmosis appears to be rare among hematopoietic cell transplant recipients [<a href="#rid26">26-30</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Tumor necrosis factor-alpha inhibitors</span><span class="headingEndMark"> — </span>TNF-alpha inhibitors, including <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">infliximab</a>, <a class="drug drug_general" data-topicid="8925" href="/z/d/drug information/8925.html" rel="external">etanercept</a>, <a class="drug drug_general" data-topicid="8583" href="/z/d/drug information/8583.html" rel="external">adalimumab</a>, and others, are an increasingly reported cause of disseminated histoplasmosis in patients with rheumatoid arthritis, inflammatory bowel disease, and other diseases treated with these agents [<a href="#rid11">11,12,18,31-33</a>]. Histoplasmosis in this patient population is further discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1410.html" rel="external">"Tumor necrosis factor-alpha inhibitors: Bacterial, viral, and fungal infections", section on 'Histoplasmosis'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">HIV infection</span><span class="headingEndMark"> — </span>Although HIV infection is a significant risk factor for disseminated histoplasmosis, the risk of disease has declined in the United States with effective antiretroviral therapy [<a href="#rid34">34</a>]. However, histoplasmosis remains a major problem in persons with HIV in Latin America [<a href="#rid35">35,36</a>]. Detailed discussions of histoplasmosis in patients with HIV are found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV"</a> and  <a class="medical medical_review" href="/z/d/html/6996.html" rel="external">"Treatment of histoplasmosis in patients with HIV"</a>.)</p><p class="headingAnchor" id="H2109076450"><span class="h2">Other risk factors</span><span class="headingEndMark"> — </span>Other risk factors that predispose to disseminated histoplasmosis include primary and acquired cellular immunodeficiency, receipt of other immunosuppressive medications, such as glucocorticoids, and extremes of age. At least one report noted that risk also may be increased during pregnancy [<a href="#rid37">37</a>].</p><p>A separate group of patients, most of whom are middle-aged to older men, may develop chronic disseminated histoplasmosis and have no known underlying immunosuppression [<a href="#rid2">2</a>]. In these patients, unidentified defects in cellular immunity likely explain their inability to control the infection. (See <a class="local">'Clinical manifestations'</a> below.)</p><p class="headingAnchor" id="H9"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H534928888"><span class="h2">Time course and spectrum of disease</span><span class="headingEndMark"> — </span>The clinical manifestations of disseminated histoplasmosis, as well as the timing of presentation, vary based on the host's immune function and the degree of exposure to the fungus [<a href="#rid2">2,4</a>]. Patients may present shortly after the exposure or years later and rarely may experience asymptomatic periods interrupted by symptomatic relapses [<a href="#rid2">2</a>]. Disseminated histoplasmosis occurs in two classically described forms (acute and chronic) based upon the time course of the illness [<a href="#rid2">2</a>]. The term progressive disseminated histoplasmosis often refers to severe disease involving multiple organ systems, usually among immunocompromised patients. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute infection</strong> – Acute infection is mostly seen in infants and heavily immunocompromised hosts, such as persons with advanced HIV. Patients with acute infection present with fever, fatigue, hepatosplenomegaly, and pancytopenia. Diarrhea and dyspnea occur less commonly. Unusual manifestations, including splenic infarction and ulcerative skin lesions occurring within three months of initiating antiretroviral therapy have been reported in a few patients with HIV and have been attributed to immune reconstitution inflammatory syndrome [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV"</a> and  <a class="medical medical_review" href="/z/d/html/3762.html" rel="external">"Immune reconstitution inflammatory syndrome"</a>.) </p><p></p><p class="bulletIndent1">Severely immunocompromised patients can also present with overwhelming infection manifested by shock, respiratory distress, hepatic and renal failure, obtundation, and coagulopathy [<a href="#rid15">15</a>]. These manifestations were more common early in the AIDS epidemic. After the introduction of potent antiretroviral therapy, severe acute disseminated histoplasmosis in patients with HIV is seen less often. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic infection </strong>– Chronic infection has been described primarily in immunocompetent older adults. Patients with chronic histoplasmosis often present with pancytopenia, hepatosplenomegaly, oropharyngeal lesions, and symptoms and signs of adrenal gland dysfunction. They may have skin lesions and gastrointestinal involvement, and they often are ill for weeks to months before the diagnosis is made. </p><p></p><p>Not all patients with disseminated histoplasmosis can be placed neatly into these two distinct syndromes. Patients who have <em>H. capsulatum</em> documented at even one extrapulmonary site, such as extrathoracic lymphadenopathy or isolated central nervous system (CNS) infection, are classified as disseminated histoplasmosis [<a href="#rid39">39</a>]. Many of these patients do not have the findings noted above but rather have findings related to the predominant organ involved [<a href="#rid39">39</a>]. A review of disseminated histoplasmosis comparing immunocompetent with immunocompromised patients noted that patients who were immunocompetent were less likely to have fever and gastrointestinal manifestations, but night sweats, respiratory symptoms, and skin lesions were similar in both groups. Oropharyngeal lesions and symptoms and laboratory findings suggesting adrenal insufficiency were not found in that series [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Gastrointestinal disease</span><span class="headingEndMark"> — </span>Gastrointestinal disease manifestations are uncommon. Involvement may occur all along the gastrointestinal tract but most often involves the colon or ileum, especially the ileocecal area. Clinical symptoms include nausea, vomiting, and diarrhea; clinical findings include ulcerations resembling inflammatory bowel disease and polypoid masses resembling cancer  (<a class="graphic graphic_diagnosticimage graphicRef69668" href="/z/d/graphic/69668.html" rel="external">image 1</a>) [<a href="#rid2">2,5</a>]. Less common presentations include painful ulcerative mouth lesions with heaped up borders resembling malignancy, dysphagia, esophagitis, abdominal pain, gastrointestinal bleeding, and colonic perforation.</p><p>Subclinical gastrointestinal involvement is much more common; approximately 70 percent of patients with disseminated histoplasmosis have involvement of the gastrointestinal tract at autopsy [<a href="#rid2">2</a>]. Histologic examination reveals infected macrophages in the lamina propria. </p><p>Patients with fever and intestinal lesions on colonoscopy who are from endemic areas or who have a history of possible exposure to <em>H. capsulatum </em>should be evaluated for histoplasmosis. Care must be taken to exclude histoplasmosis as the cause for ulcerative bowel disease before initiating immunosuppressive therapy, especially with TNF-alpha inhibitors [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/z/d/html/2461.html" rel="external">"Diagnosis and treatment of disseminated histoplasmosis in patients without HIV", section on 'Diagnosis of disseminated histoplasmosis'</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Skin involvement</span><span class="headingEndMark"> — </span>Skin lesions are seen much more frequently in persons with advanced HIV [<a href="#rid41">41-43</a>]. The lesions seen include nodules, papules, plaques, ulcers, vesicles, pustules, abscesses, and generalized dermatitis  (<a class="graphic graphic_picture graphicRef78902" href="/z/d/graphic/78902.html" rel="external">picture 3</a>). Less common manifestations include exfoliative erythroderma, necrotizing vasculitis, cellulitis, panniculitis, petechiae, purpura, and ecchymoses.</p><p><em>H. capsulatum</em> is present on fungal stains of skin biopsy specimens of lesions in most cases of HIV-associated disseminated histoplasmosis [<a href="#rid44">44</a>]. Diagnosis of skin involvement can be difficult because organisms may primarily be seen extracellularly and pathologic findings may resemble leukocytoclastic vasculitis [<a href="#rid45">45</a>]. Presence of an infiltrate composed of macrophages that are heavily infected with <em>H. capsulatum</em> is a characteristic finding on histopathology; granulomas are uncommon.  </p><p class="headingAnchor" id="H12"><span class="h2">Adrenal involvement</span><span class="headingEndMark"> — </span>Overt adrenal insufficiency is found in less than 10 percent of cases, although adrenal involvement is common in autopsied cases [<a href="#rid2">2</a>]. Adrenal involvement may be unilateral or bilateral  (<a class="graphic graphic_diagnosticimage graphicRef82224" href="/z/d/graphic/82224.html" rel="external">image 2</a>). The adrenal sinusoids may be diffusely involved or may have focal collections of infected macrophages in the medulla, zona reticularis of the cortex, or corticomedullary junction. Perivasculitis may be a prominent feature, causing thrombosis and infarction of the adrenal gland and adrenal insufficiency. Thus, clinicians should consider histoplasmosis in patients with adrenal masses or adrenal insufficiency and should consider adrenal insufficiency in patients with disseminated histoplasmosis who present with electrolyte abnormalities (high serum potassium levels and low serum sodium levels), orthostatic hypotension, and/or hypoglycemia.</p><p class="headingAnchor" id="H13"><span class="h2">Central nervous system disease</span><span class="headingEndMark"> — </span>Studies report CNS involvement in 5 to 20 percent of cases of disseminated histoplasmosis, with higher incidence in patients with underlying immunosuppressive disorders [<a href="#rid5">5,46,47</a>]. Clinical presentations include meningitis with other symptoms of disseminated histoplasmosis, isolated chronic meningitis, cerebral vasculitis with stroke syndrome, focal brain lesions, encephalitis, and localized involvement of the spinal cord [<a href="#rid46">46</a>]. Histoplasmosis should be considered in the differential diagnosis of patients who are from endemic areas or who have a history of possible exposure to <em>H. capsulatum </em>and present with chronic meningitis, focal brain or spinal cord lesions, or encephalitis [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/z/d/html/2461.html" rel="external">"Diagnosis and treatment of disseminated histoplasmosis in patients without HIV", section on 'Special considerations for diagnosing meningitis'</a>.)</p><p class="headingAnchor" id="H1863089559"><span class="h2">Endocarditis</span><span class="headingEndMark"> — </span>Endocarditis is a rare manifestation of <em>H. capsulatum</em> infection [<a href="#rid49">49-53</a>] and is often difficult to diagnose. Symptoms typically last for weeks to months before the diagnosis is made. <em>H. capsulatum</em> can affect native and prosthetic valves, as well as aortic grafts [<a href="#rid54">54</a>].</p><p>In a multicenter study of 14 persons with proven <em>Histoplasma</em> endocarditis diagnosed over a 10-year period, 10 had an infected prosthetic aortic valve, three had an infected native mitral valve, and one had an infected left atrial myxoma [<a href="#rid53">53</a>]. Diagnosis was delayed a median of seven weeks; blood cultures yielded the organism in only six patients, but 11 had a positive serum or urine <em>Histoplasma</em> antigen assay. Mortality was 22 percent with death occurring from two days to two months after diagnosis.     </p><p>A literature review of 61 cases of <em>H. capsulatum</em> endocarditis diagnosed from 1945 to 2020 compared native and prosthetic valve endocarditis [<a href="#rid55">55</a>]. Thirty-six patients had native valve endocarditis, with 58 percent involving the aortic valve; 25 patients had prosthetic valve endocarditis, with 76 percent involving the aortic valve. Symptoms were present for a mean of 10 months for native valve endocarditis and six months for prosthetic valve endocarditis. Embolic complications occurred equally often in native valve and prosthetic valve endocarditis. The mean case fatality rate was 88 percent prior to 1970 compared with 21 percent after 1970. </p><p class="headingAnchor" id="H14"><span class="h2">Other</span><span class="headingEndMark"> — </span>Uncommon manifestations of disseminated histoplasmosis include [<a href="#rid2">2,3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Thrombotic microangiopathy [<a href="#rid56">56</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Hemophagocytic lymphohistiocytosis [<a href="#rid57">57,58</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Hypercalcemia due to calcitriol production by activated macrophages [<a href="#rid59">59,60</a>] (see  <a class="medical medical_review" href="/z/d/html/841.html" rel="external">"Hypercalcemia in granulomatous diseases"</a>). Hypercalcemia may lead to the incorrect diagnosis of sarcoidosis [<a href="#rid61">61</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Chorioretinitis [<a href="#rid62">62</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Pleuritis [<a href="#rid63">63</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Pericarditis [<a href="#rid64">64</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Peritonitis [<a href="#rid65">65</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Pancreatitis and cholecystitis [<a href="#rid66">66</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Panniculitis [<a href="#rid67">67</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Mastitis [<a href="#rid68">68</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Osteomyelitis and septic arthritis of both native and prosthetic joints [<a href="#rid69">69-71</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Tenosynovitis [<a href="#rid72">72</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Prostatitis [<a href="#rid73">73</a>], epididymitis, or involvement of the penis or vagina [<a href="#rid74">74-76</a>].</p><p></p><p class="headingAnchor" id="H797800596"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/120865.html" rel="external">"Society guideline links: Histoplasmosis"</a>.)</p><p class="headingAnchor" id="H444554108"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/87577.html" rel="external">"Patient education: Histoplasmosis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H30598196"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General </strong>–<strong> </strong>Histoplasmosis is the most prevalent endemic mycosis in the United States. Most infections are asymptomatic or self-limited, but some individuals develop acute pulmonary infections or severe and progressive disseminated infection. Severe illness is unusual except in the host with altered immunity and those at the extremes of age. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><em>Histoplasma capsulatum</em> is a thermally dimorphic fungus, growing as a mold in the environment and as a yeast at 37°C. Infection develops when <em>Histoplasma </em>microconidia are inhaled into the lungs, where they change into the yeast form. In patients with disseminated infection, macrophages are typically engorged with yeasts, supporting the important role of intracellular proliferation of the organism. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>T cell immunity plays the predominant role in recovery from histoplasmosis. Once cellular immunity to <em>Histoplasma</em> develops, macrophages become activated to kill the organism. Failure to activate macrophage fungicidal capacity appears to be the key defect in immunity to <em>H. capsulatum</em> in patients with disseminated histoplasmosis. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reinfection can occur in patients who previously had documented histoplasmosis. In persons with impaired immunity or in those with massive exposure, reexposure to <em>H. capsulatum</em> can overcome residual host defenses against this organism. Reactivation of latent histoplasmosis can also occur in immunocompromised patients. Presumably, viable organisms persist in the tissues following recovery from the initial episode of histoplasmosis. (See <a class="local">'Reinfection and reactivation of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathology </strong>–<strong> </strong>At autopsy, many patients with disseminated histoplasmosis demonstrate involvement of the liver, spleen, lymph nodes, bone marrow, adrenal glands, central nervous system (CNS), and gastrointestinal tract mucosa. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Most patients with disseminated histoplasmosis have underlying conditions that impair their ability to defend against intracellular pathogens. A variety of conditions have been found to predispose to disseminated histoplasmosis, including:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>HIV infection</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Primary immunodeficiency or other immunosuppressive disorders</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Immunosuppressive medications, such as glucocorticoids, antirejection therapies in solid organ transplant recipients, or tumor necrosis factor (TNF)-alpha inhibitor therapies</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Extremes of age (see <a class="local">'Risk factors'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A separate group of patients have chronic disseminated histoplasmosis and have no known underlying immunosuppression. In these patients, unidentified defects in cellular immunity likely explain their inability to control the infection. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The clinical manifestations of disseminated histoplasmosis as well as the timing of presentation vary based on host immunity and the degree of exposure to the fungus. Patients may present shortly after the exposure or years later and rarely may experience asymptomatic periods interrupted by symptomatic relapses. Disseminated histoplasmosis occurs in two forms, based upon the time course of the illness and the extent of infection: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Acute infection, which is mostly seen in infants and heavily immunocompromised hosts</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Chronic infection, noted more often in older adults (See <a class="local">'Time course and spectrum of disease'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severely immunocompromised patients, such as those with AIDS or those receiving treatment with immunosuppressive medications, may present with overwhelming infection manifested by shock, respiratory distress, hepatic and renal failure, obtundation, and coagulopathy. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with chronic infection often present with pancytopenia, hepatosplenomegaly, hepatic enzyme elevation, and oropharyngeal lesions. Other sites include the skin, brain, and adrenal glands  (<a class="graphic graphic_diagnosticimage graphicRef70552" href="/z/d/graphic/70552.html" rel="external">image 3</a> and <a class="graphic graphic_diagnosticimage graphicRef82224" href="/z/d/graphic/82224.html" rel="external">image 2</a> and <a class="graphic graphic_figure graphicRef50609" href="/z/d/graphic/50609.html" rel="external">figure 1</a>). (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="headingAnchor" id="H3568672636"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Joseph Wheat, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Chu JH, Feudtner C, Heydon K, et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 2006; 42:822.</a></li><li><a class="nounderline abstract_t">Goodwin RA Jr, Shapiro JL, Thurman GH, et al. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980; 59:1.</a></li><li><a class="nounderline abstract_t">Sathapatayavongs B, Batteiger BE, Wheat J, et al. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 1983; 62:263.</a></li><li><a class="nounderline abstract_t">Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 2007; 20:115.</a></li><li><a class="nounderline abstract_t">Assi MA, Sandid MS, Baddour LM, et al. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 2007; 86:162.</a></li><li class="breakAll">Deepe GS Jr, Bullock WE. Histoplasmosis: a granulomatous inflammatory response. In: Basic Principals and Clinical Correlates, Gallin JI, Goldstein IM, Snyderman R (Eds), Raven, New York 1988. p.733.</li><li><a class="nounderline abstract_t">Horwath MC, Fecher RA, Deepe GS Jr. Histoplasma capsulatum, lung infection and immunity. Future Microbiol 2015; 10:967.</a></li><li><a class="nounderline abstract_t">Garfoot AL, Rappleye CA. Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis. FEBS J 2016; 283:619.</a></li><li><a class="nounderline abstract_t">Woods JP. Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis. J Microbiol 2016; 54:265.</a></li><li><a class="nounderline abstract_t">Zhou P, Sieve MC, Tewari RP, Seder RA. Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. Infect Immun 1997; 65:936.</a></li><li><a class="nounderline abstract_t">Hage CA, Bowyer S, Tarvin SE, et al. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50:85.</a></li><li><a class="nounderline abstract_t">Vergidis P, Avery RK, Wheat LJ, et al. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis 2015; 61:409.</a></li><li><a class="nounderline abstract_t">Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005; 41:e38.</a></li><li><a class="nounderline abstract_t">Lionakis MS, Netea MG, Holland SM. Mendelian genetics of human susceptibility to fungal infection. Cold Spring Harb Perspect Med 2014; 4.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361.</a></li><li><a class="nounderline abstract_t">Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med 1978; 64:94.</a></li><li><a class="nounderline abstract_t">Keath EJ, Kobayashi GS, Medoff G. Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene. J Clin Microbiol 1992; 30:2104.</a></li><li><a class="nounderline abstract_t">Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38:1261.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96:159.</a></li><li><a class="nounderline abstract_t">Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993; 328:373.</a></li><li><a class="nounderline abstract_t">Cuellar-Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49:710.</a></li><li><a class="nounderline abstract_t">Assi M, Martin S, Wheat LJ, et al. Histoplasmosis after solid organ transplant. Clin Infect Dis 2013; 57:1542.</a></li><li><a class="nounderline abstract_t">Nieto-Ríos JF, Serna-Higuita LM, Guzman-Luna CE, et al. Histoplasmosis in renal transplant patients in an endemic area at a reference hospital in Medellin, Colombia. Transplant Proc 2014; 46:3004.</a></li><li><a class="nounderline abstract_t">Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000; 343:1163.</a></li><li><a class="nounderline abstract_t">Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999; 18:662.</a></li><li><a class="nounderline abstract_t">Kauffman CA, Freifeld AG, Andes DR, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis 2014; 16:213.</a></li><li><a class="nounderline abstract_t">Peterson MW, Pratt AD, Nugent KM. Pneumonia due to Histoplasma capsulatum in a bone marrow transplant recipient. Thorax 1987; 42:698.</a></li><li><a class="nounderline abstract_t">Walsh TJ, Catchatourian R, Cohen H. Disseminated histoplasmosis complicating bone marrow transplantation. Am J Clin Pathol 1983; 79:509.</a></li><li class="breakAll">Kauffman, CA. Endemic mycoses after hematopoietic stem cell or solid organ transplantation. In: Transplant Infections, 3rd edition, Bowden, R, Ljungman, P, Snydman, DR (Eds), Lippincott Williams and Wilkins, Philadelphia 2010. p.607.</li><li><a class="nounderline abstract_t">Natarajan M, Swierzbinski MJ, Maxwell S, et al. Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature. Open Forum Infect Dis 2017; 4:ofx041.</a></li><li><a class="nounderline abstract_t">Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002; 46:2565.</a></li><li><a class="nounderline abstract_t">Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy. Drugs 2009; 69:1403.</a></li><li><a class="nounderline abstract_t">Bogorodskaya M, El Chakhtoura NG, Salata RA. Disseminated histoplasmosis in patients receiving tumor necrosis factor-α inhibitors: A case series and review. Infect Dis Clin Pract 2016; 24:261.</a></li><li><a class="nounderline abstract_t">Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 2001; 32:1215.</a></li><li><a class="nounderline abstract_t">Adenis AA, Valdes A, Cropet C, et al. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis 2018; 18:1150.</a></li><li><a class="nounderline abstract_t">Samayoa B, Roy M, Cleveland AA, et al. High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. Am J Trop Med Hyg 2017; 97:42.</a></li><li><a class="nounderline abstract_t">Whitt SP, Koch GA, Fender B, et al. Histoplasmosis in pregnancy: case series and report of transplacental transmission. Arch Intern Med 2004; 164:454.</a></li><li><a class="nounderline abstract_t">Shelburne SA 3rd, Visnegarwala F, Adams C, et al. Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy. Am J Med 2005; 118:1038.</a></li><li><a class="nounderline abstract_t">Franklin AD, Larson L, Rauseo AM, et al. A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status. Med Mycol 2021.</a></li><li><a class="nounderline abstract_t">Goulet CJ, Moseley RH, Tonnerre C, et al. Clinical problem-solving. The unturned stone. N Engl J Med 2005; 352:489.</a></li><li><a class="nounderline abstract_t">Cunha VS, Zampese MS, Aquino VR, et al. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol 2007; 32:250.</a></li><li><a class="nounderline abstract_t">Karimi K, Wheat LJ, Connolly P, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002; 186:1655.</a></li><li><a class="nounderline abstract_t">Tobón AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73:576.</a></li><li><a class="nounderline abstract_t">Cohen PR, Bank DE, Silvers DN, Grossman ME. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J Am Acad Dermatol 1990; 23:422.</a></li><li><a class="nounderline abstract_t">Eidbo J, Sanchez RL, Tschen JA, Ellner KM. Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome. Am J Surg Pathol 1993; 17:110.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1990; 69:244.</a></li><li><a class="nounderline abstract_t">Wheat J, Myint T, Guo Y, et al. Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. Medicine (Baltimore) 2018; 97:e0245.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005; 40:844.</a></li><li><a class="nounderline abstract_t">Bhatti S, Vilenski L, Tight R, Smego RA Jr. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect 2005; 51:2.</a></li><li><a class="nounderline abstract_t">Gaynes RP, Gardner P, Causey W. Prosthetic valve endocarditis caused by Histoplasma capsulatum. Arch Intern Med 1981; 141:1533.</a></li><li><a class="nounderline abstract_t">Ellis ME, Al-Abdely H, Sandridge A, et al. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001; 32:50.</a></li><li><a class="nounderline abstract_t">Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002; 122:302.</a></li><li><a class="nounderline abstract_t">Riddell J 4th, Kauffman CA, Smith JA, et al. Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore) 2014; 93:186.</a></li><li><a class="nounderline abstract_t">Ledtke C, Rehm SJ, Fraser TG, et al. Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature. Arch Pathol Lab Med 2012; 136:640.</a></li><li><a class="nounderline abstract_t">Boyanton BL Jr, Boamah H, Lauter CB. Native vs Prosthetic Valve Histoplasma capsulatum Infective Endocarditis: A Case Report and Systemic Literature Review Comparing Patient Presentation, Treatment Modalities, Clinical Outcomes, and Diagnostic Laboratory Testing. Open Forum Infect Dis 2021; 8:ofab360.</a></li><li><a class="nounderline abstract_t">Dwyre DM, Bell AM, Siechen K, et al. Disseminated histoplasmosis presenting as thrombotic microangiopathy. Transfusion 2006; 46:1221.</a></li><li><a class="nounderline abstract_t">Koduri PR, Chundi V, DeMarais P, et al. Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 1995; 21:1463.</a></li><li><a class="nounderline abstract_t">Townsend JL, Shanbhag S, Hancock J, et al. Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature. Open Forum Infect Dis 2015; 2:ofv055.</a></li><li><a class="nounderline abstract_t">Walker JV, Baran D, Yakub N, Freeman RB. Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis. Confusion with sarcoidosis.. JAMA 1977; 237:1350.</a></li><li><a class="nounderline abstract_t">Murray JJ, Heim CR. Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D. Am J Med 1985; 78:881.</a></li><li><a class="nounderline abstract_t">Gulati M, Saint S, Tierney LM Jr. Clinical problem-solving. Impatient inpatient care. N Engl J Med 2000; 342:37.</a></li><li><a class="nounderline abstract_t">Macher A, Rodrigues MM, Kaplan W, et al. Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome. Ophthalmology 1985; 92:1159.</a></li><li><a class="nounderline abstract_t">Kilburn CD, McKinsey DS. Recurrent massive pleural effusion due to pleural, pericardial, and epicardial fibrosis in histoplasmosis. Chest 1991; 100:1715.</a></li><li><a class="nounderline abstract_t">Young EJ, Vainrub B, Musher DM. Pericarditis due to histoplasmosis. JAMA 1978; 240:1750.</a></li><li><a class="nounderline abstract_t">Reddy PA, Brasher CA, Christianson C, et al . Peritonitis due to histoplasmosis. Ann Intern Med 1969; 72:79.</a></li><li><a class="nounderline abstract_t">Patrick CC, Flynn PM, Henwick S, Pui CH. Disseminated histoplasmosis presenting as a cystic duct obstruction. Pediatr Infect Dis J 1992; 11:593.</a></li><li><a class="nounderline abstract_t">Pottage JC Jr, Trenholme GM, Aronson IK, Harris AA. Panniculitis associated with histoplasmosis and alpha 1-antitrypsin deficiency. Am J Med 1983; 75:150.</a></li><li><a class="nounderline abstract_t">Osborne BM. Granulomatous mastitis caused by histoplasma and mimicking inflammatory breast carcinoma. Hum Pathol 1989; 20:47.</a></li><li><a class="nounderline abstract_t">Darouiche RO, Cadle RM, Zenon GJ, et al. Articular histoplasmosis. J Rheumatol 1992; 19:1991.</a></li><li><a class="nounderline abstract_t">Jones PG, Rolston K, Hopfer RL. Septic arthritis due to Histoplasma capsulatum in a leukaemic patient. Ann Rheum Dis 1985; 44:128.</a></li><li><a class="nounderline abstract_t">Fowler VG Jr, Nacinovich FM, Alspaugh JA, Corey GR. Prosthetic joint infection due to Histoplasma capsulatum: case report and review. Clin Infect Dis 1998; 26:1017.</a></li><li><a class="nounderline abstract_t">Cucurull E, Sarwar H, Williams CS 4th, Espinoza LR. Localized tenosynovitis caused by Histoplasma capsulatum: case report and review of the literature. Arthritis Rheum 2005; 53:129.</a></li><li><a class="nounderline abstract_t">Zighelboim J, Goldfarb RA, Mody D, et al. Prostatic abscess due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome. J Urol 1992; 147:166.</a></li><li><a class="nounderline abstract_t">Kauffman CA, Slama TG, Wheat LJ. Histoplasma capsulatum epididymitis. J Urol 1981; 125:434.</a></li><li><a class="nounderline abstract_t">Sills M, Schwartz A, Weg JG. Conjugal histoplasmosis. A consequence of progressive dissemination in the index case after steroid therapy. Ann Intern Med 1973; 79:221.</a></li><li><a class="nounderline abstract_t">Jayalakshmi P, Goh KL, Soo-Hoo TS, Daud A. Disseminated histoplasmosis presenting as penile ulcer. Aust N Z J Med 1990; 20:175.</a></li></ol></div><div id="topicVersionRevision">Topic 2455 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16477560" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hospitalizations for endemic mycoses: a population-based national study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7356773" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Disseminated histoplasmosis: clinical and pathologic correlations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6312246" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223625" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Histoplasmosis: a clinical and laboratory update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17505255" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17505255" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26059620" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Histoplasma capsulatum, lung infection and immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26235362" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26920886" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9038300" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19951231" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25870331" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Histoplasmosis complicating tumor necrosis factor-αblocker therapy: a retrospective analysis of 98 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16028145" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24890837" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Mendelian genetics of human susceptibility to fungal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2233233" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/623139" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1354224" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Typing of Histoplasma capsulatum by restriction fragment length polymorphisms in a nuclear gene.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15127338" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Granulomatous infectious diseases associated with tumor necrosis factor antagonists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7059062" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8093633" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19635026" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24046304" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Histoplasmosis after solid organ transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25420811" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Histoplasmosis in renal transplant patients in an endemic area at a reference hospital in Medellin, Colombia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11036122" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Transmission of Histoplasma capsulatum by organ transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10534190" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A case of disseminated histoplasmosis likely due to infection from a liver allograft.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24589027" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3317978" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Pneumonia due to Histoplasma capsulatum in a bone marrow transplant recipient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6340463" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Disseminated histoplasmosis complicating bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6340463" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Disseminated histoplasmosis complicating bone marrow transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28470019" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12384912" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19634920" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Disseminated histoplasmosis in patients receiving tumor necrosis factor-αinhibitors: A case series and review</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283812" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30146320" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28719316" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14980998" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Histoplasmosis in pregnancy: case series and report of transplacental transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16164892" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33443574" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A comparison of presentations and outcomes of histoplasmosis across patients with varying immune status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15689588" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Clinical problem-solving. The unturned stone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17397349" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12447743" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16172484" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2212140" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8422108" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2197524" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Histoplasma capsulatum infections of the central nervous system. A clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29595679" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15736018" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Diagnosis and management of central nervous system histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15979483" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Histoplasma endocarditis: clinical and mycologic features and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7283568" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prosthetic valve endocarditis caused by Histoplasma capsulatum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11118386" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Fungal endocarditis: evidence in the world literature, 1965-1995.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12114375" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Fungal endocarditis, 1995-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25181311" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22646271" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34381842" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Native vs Prosthetic Valve Histoplasma capsulatum Infective Endocarditis: A Case Report and Systemic Literature Review Comparing Patient Presentation, Treatment Modalities, Clinical Outcomes, and Diagnostic Laboratory Testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16836570" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Disseminated histoplasmosis presenting as thrombotic microangiopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8749633" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26380347" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/576482" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Histoplasmosis with hypercalcemia, renal failure, and papillary necrosis. Confusion with sarcoidosis..</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3993669" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Hypercalcemia in disseminated histoplasmosis. Aggravation by vitamin D.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10620648" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Clinical problem-solving. Impatient inpatient care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2413418" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1959418" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Recurrent massive pleural effusion due to pleural, pericardial, and epicardial fibrosis in histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/691177" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Pericarditis due to histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Peritonitis due to histoplasmosis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1528653" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Disseminated histoplasmosis presenting as a cystic duct obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6305193" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Panniculitis associated with histoplasmosis and alpha 1-antitrypsin deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2912873" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Granulomatous mastitis caused by histoplasma and mimicking inflammatory breast carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1294755" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Articular histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3856420" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Septic arthritis due to Histoplasma capsulatum in a leukaemic patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9564509" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Prosthetic joint infection due to Histoplasma capsulatum: case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15696561" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Localized tenosynovitis caused by Histoplasma capsulatum: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1729520" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Prostatic abscess due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7206103" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Histoplasma capsulatum epididymitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4740806" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Conjugal histoplasmosis. A consequence of progressive dissemination in the index case after steroid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2344324" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Disseminated histoplasmosis presenting as penile ulcer.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
